WS #13302

07:22→07:52 UTC

From 473 msgs · 7 key-dev

AstraZeneca in talks to acquire BMS in ~$400B deal, creating world's 4th largest drugmaker; AZN shares drop 7% on deal risk.

AstraZeneca-BMS merger talks

AstraZeneca in talks to acquire BMS in ~$400B deal, creating world's 4th largest drugmaker; AZN shares drop 7% on deal risk.